Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineage-directed therapies
Article in Haematologica (August 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype
Article in Boletín Médico del Hospital Infantil de México (June 2023)
KMT2A amplification in B lymphoblastic leukaemia
Article in Pathology (March 2023)